CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, and Genevant ...

Nicole F. Steinmetz, the George J. Picha Professor in Biomaterials, member of the Case Comprehensive Cancer Center and director of the Center for Bio-Nanotechnology at Case Western Reserve University ...

Researchers at Columbia University College of Dental Medicine have developed an exosome-based platform, "safeEXO-Cas," that significantly enhances the delivery of CRISPR/Cas9 genome editing components ...

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced it has entered into a license agreement with Genentech, a member of the Roche Group, to develop intravenously ...

Cambridge, Mass., May 26, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Human Life Foundation ...

Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM4808, an AI-driven potential best-in-class oral PHD ...

Francis OnoiribholoProfessor Felix Okechukwu Emelike, Professor of Haematology and Blood Transfusion Science in the Faculty of Medical Sciences, Ambrose Alli University (AAU), Ekpoma, has called for ...

The Director-General of the Nigeria Natural Medicine Development Agency, Prof Martins Emeje, says the agency has developed 23 new natural medicines, including remedies for diarrhoea, peptic ulcers, ...

The collaboration between Insilico and HLFM aims to jointly develop a super-intelligence AI foundation model to decode the biological mechanisms of aging and enable predictive healthcare. Within this ...